ÂÜÀòÂÒÂ×

Rebecca Spalding was a former financial journalist for Bloomberg and Reuters with extensive experience covering the biotechnology industry, including FDA approvals, pivotal data readouts, IPOs, and mergers. She co-led on Reuters reporting team covering COVID-19 vaccine rollout in the U.S., including White House, CDC, and Operation Warp Speed briefings. She holds an M.A. in business and economics reporting from New York University and B.A. in English from Barnard College, Columbia University.